论文信息 - ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination - 字舞流文

ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination

G. Peoples | G. Clifton | T. Vreeland | A. Adams

[1] Talia Fisher. Trial by Design , 2023, American Philosophical Quarterly.

[2] T. Wagner,et al. A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis , 2021, Annals of Surgical Oncology.

[3] R. Mandal,et al. Recent developments and obstacles in the treatment of melanoma with BRAF and MEK inhibitors. , 2018, Critical reviews in oncology/hematology.

[4] D. Schadendorf,et al. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma , 2018, The New England journal of medicine.

[5] H. Kohrt,et al. Critical issues in cancer vaccine trial design. , 2015, Vaccine.

[6] Jennifer Kleponis,et al. Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors , 2015, Cancer biology & medicine.